Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialResearch in context

Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialResearch in context

Summary: Background: The SECURE trial (NCT02596126) demonstrated the efficacy of the cardiovascular polypill (“CV-Polypill”–acetyl salicylic acid, atorvastatin and ramipril) in reducing the risk of recurrent major cardiovascular events compared with standard care when initiated within six months of...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas Gaziano, José María Castellano, Amy Dymond, Alissa Looby, Stuart Mealing, Ruth Owen, Stuart Pocock, José Ramón González-Juanatey, Alberto Cordero, Antonio Fernández-Ortiz, Aleš Linhart, François Schiele, Wolfram Doehner, Luisa Ojeda Fernández, Valentín Fuster
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:The Lancet Regional Health. Europe
Subjects:
Cost-effectiveness analysis
Cardiovascular prevention
CV-Polypill
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776225001401
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666776225001401

Similar Items